Bicara Therapeutics Inc (BCAX)
NASDAQ
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Return on Assets (%) | -44.435 |
Return on Equity (%) | 69.887 |
Return on Invested Capital (%) | -36.868 |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Book Value Per Share | 36.916 |
Earnings Per Share | -8.783 |
Cash Per Share | 38.932 |
Working Capital Per Share | 36.491 |
Operating Profit Per Share | N/A |
EBIT Per Share | -8.782 |
EBITDA Per Share | -8.782 |
Free Cash Flow Per Share | -8.687 |
Year End December 30 2023 | 2023 |
---|---|
Current Ratio | N/A |
Quick Ratio | N/A |
Inventory Turnover (Days) | N/A |
Shares Outstanding | 5.92M |
Year End December 30 2023 | Sep 2024 |
---|---|
USD ($) | |
Shares Outstanding | N/A |
Return on Assets (%) | N/A |
Return on Equity (%) | N/A |
Return on Invested Capital (%) | N/A |
Operating Margin (%) | N/A |
Net Profit Margin (%) | N/A |
Sales Per Share | N/A |
Book Value Per Share | N/A |
Earnings Per Share | N/A |
Cash Per Share | N/A |
Working Capital Per Share | N/A |
Operating Profit Per Share | N/A |
EBIT Per Share | N/A |
EBITDA Per Share | N/A |
Free Cash Flow Per Share | N/A |
Current Ratio | N/A |
Quick Ratio | N/A |
Inventory Turnover (Days) | N/A |
Market Cap | 666.05M |
Price to Earnings Ratio | -12.81 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.89 |
Price to Book Ratio | 3.05 |
Dividend Yield | - |
Shares Outstanding | 54.42M |
Average Volume (1 week) | 347.23k |
Average Volume (1 Month) | 384.92k |
52 Week Change | -53.37% |
52 Week High | 27.95 |
52 Week Low | 11.10 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.